These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 1852761

  • 1. Anticoagulant and antithrombotic action of the synthetic thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginine nitrile.
    Kaiser B, Richter M, Hauptmann J, Markwardt F.
    Pharmazie; 1991 Feb; 46(2):128-31. PubMed ID: 1852761
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.
    Jackson CV, Crowe VG, Frank JD, Wilson HC, Coffman WJ, Utterback BG, Jakubowski JA, Smith GF.
    J Pharmacol Exp Ther; 1992 May; 261(2):546-52. PubMed ID: 1578372
    [Abstract] [Full Text] [Related]

  • 3. Comparative study on the antithrombotic effects of a synthetic thrombin inhibitor and of heparin in animal models.
    Hauptmann J, Barth A, Schönberger FP, Markwardt F.
    Biomed Biochim Acta; 1983 May; 42(7-8):959-65. PubMed ID: 6651812
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition by D-MePhe-Pro-Arg-H (GYKI-14766) of thrombus growth in experimental models of thrombosis.
    Bagdy D, Szabó G, Barabás E, Bajusz S.
    Thromb Haemost; 1992 Aug 03; 68(2):125-9. PubMed ID: 1412156
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacological studies on the low molecular weight heparin derivative CY 216.
    Kaiser B, Kühnemuth G, Markwardt F.
    Pharmazie; 1990 Jul 03; 45(7):522-4. PubMed ID: 2173004
    [Abstract] [Full Text] [Related]

  • 11. Antithrombotic efficacy of thrombin inhibitor L-374,087: intravenous activity in a primate model of venous thrombus extension and oral activity in a canine model of primary venous and coronary artery thrombosis.
    Cook JJ, Gardell SJ, Holahan MA, Sitko GR, Stump GL, Wallace AA, Gilberto DB, Hare TR, Krueger JA, Dyer DL, Sanderson PE, Vacca JP, Shafer JA, Lynch JJ.
    J Pharmacol Exp Ther; 1999 Apr 03; 289(1):503-10. PubMed ID: 10087043
    [Abstract] [Full Text] [Related]

  • 12. Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding.
    Schumacher WA, Steinbacher TE, Heran CL, Seiler SM, Michel IM, Ogletree ML.
    J Pharmacol Exp Ther; 1993 Dec 03; 267(3):1237-42. PubMed ID: 8263785
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Studies on toxicity and pharmacokinetics of the synthetic thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginine nitrile.
    Kaiser B, Hauptmann J, Markwardt F.
    Pharmazie; 1991 Feb 03; 46(2):131-4. PubMed ID: 1852762
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anticoagulant and antithrombotic action of novel specific inhibitors of thrombin.
    Hauptmann J, Kaiser B, Markwardt F, Nowak G.
    Thromb Haemost; 1980 Jun 18; 43(2):118-23. PubMed ID: 7455968
    [Abstract] [Full Text] [Related]

  • 17. Experimental pharmacology of hirunorm: a novel synthetic peptide thrombin inhibitor.
    Cirillo R, Lippi A, Subissi A, Agnelli G, Criscuoli M.
    Thromb Haemost; 1996 Sep 18; 76(3):384-92. PubMed ID: 8883275
    [Abstract] [Full Text] [Related]

  • 18. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR, Lynch JJ, Sitko GR, Mellott MJ, Holahan MA, Stabilito II, Stranieri MT, Zhang G, Lynch RJ, Manno PD.
    J Pharmacol Exp Ther; 1993 Sep 18; 266(3):1501-11. PubMed ID: 8371153
    [Abstract] [Full Text] [Related]

  • 19. In vivo anticoagulant and antiplatelet effect of D-Phe-Pro-Arg-H and D-MePhe-Pro-Arg-H.
    Bagdy D, Barabás E, Szabó G, Bajusz S, Széll E.
    Thromb Haemost; 1992 Mar 02; 67(3):357-65. PubMed ID: 1641827
    [Abstract] [Full Text] [Related]

  • 20. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ, Weng D, Chesebro JH, Fuster V, Badimon L.
    Thromb Haemost; 1994 Apr 02; 71(4):511-6. PubMed ID: 8052972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.